Iceland vs Solomon Islands: Prevalence rate of obesity in adults
Iceland
22.2%
in 2024
Solomon Islands
21.8%
in 2024
Iceland rank
105th
Solomon Islands rank
108th
Prevalence rate of obesity in adults over time
- Iceland
- Solomon Islands
How they compare
Iceland currently reports 22.2% against 21.8% in Solomon Islands, a difference of 0.4%.
The two have swapped places 1 time across 45 shared years of data; in 1980 it was Solomon Islands ahead.
Iceland ranks 105th and Solomon Islands ranks 108th of 199 countries.
Across the 5 decades both report, Iceland averaged higher in 3 and Solomon Islands in 2.
Head to head by decade
| Decade | Iceland | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 8.2% | 11.4% | 3.2% | Solomon Islands |
| 1990s | 11.9% | 13.8% | 1.9% | Solomon Islands |
| 2000s | 16.5% | 16.4% | 0.0% | Iceland |
| 2010s | 19.6% | 18.9% | 0.6% | Iceland |
| 2020s | 21.6% | 21.1% | 0.4% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Iceland or Solomon Islands?
- Iceland, at 22.2% against 21.8% in Solomon Islands as of 2024.
- What is the difference in prevalence rate of obesity in adults between Iceland and Solomon Islands?
- 0.4%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Solomon Islands?
- 45 years are reported by both, from 1980 to 2024.
- How do Iceland and Solomon Islands rank globally for prevalence rate of obesity in adults?
- Iceland ranks 105th and Solomon Islands ranks 108th of 199 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.